News | PET-CT | June 13, 2016

PET-CT Reveals Adaptations of the Alcoholic Brain

Study shows how the sober brain might protect against further relapse by limiting receptor activity linked to cravings

PET-CT study, alcoholic brain, SNMMI 2016, mGluR5 receptor

Decreased mGluR5 availability in the brain of alcohol dependent individuals compared to healthy subjects. Image courtesy of Department of Nuclear Medicine and Molecular Imagine UZ Leuven, Leuven, Belgium

June 13, 2016 — An emerging molecular imaging technique may provide a way to break the perpetual cycle of abuse of alcoholism. It could signal patients’ heightened risk and lead to targeted drug treatments that reduce the compulsion to drink, said researchers presenting at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 11-15 in San Diego.

According to 2016 statistics from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), almost 7 percent of adults over the age of 18 had a drinking disorder in 2014. Alcohol-related deaths were deemed the fourth leading cause of preventable death, accounting for nearly 88,000 deaths in the same year.

Images of the brain lit up like fireworks as people experience pleasure and reward are a familiar sight, but sometimes the reward needs to be taken away. In this groundbreaking study, researchers imaged the brains of recently recovering alcoholics and found an inverse and compensatory adaptation in a particular receptor involved in memory, learning, and the sensations of pain and anxiety. This receptor, called metabotropic glutamate receptor subtype 5 (mGluR5), is found throughout the central and peripheral nervous systems but, in certain areas of the brain, it is implicated in intense cravings and addictive relapse. It seems that the brains of recovering alcoholics have adapted to the enduring state of chemical dependency by significantly hindering mGluR5 receptors in the cerebral cortex and limbic system, thereby reducing cravings.

“Alcohol addiction is a complex, chronic brain disorder associated with enormous physical, social and financial consequences worldwide, and yet current therapies remain unsatisfactory,” said senior author Koen Van Laere, M.D., Ph.D., University Hospital Gasthuisberg, Leuven, Belgium. “Our team was able to investigate, for the first time, these marked changes in the brain circuitry of alcohol-dependent humans.”

Understanding this relationship between mGluR5 and the compulsion to drink could be the key to long-term sobriety by allowing doctors to predict if patients are liable to relapse. Additionally, this research could lead to new targeted drugs that limit receptor activity in patients who lack this neuro-adaptation or are otherwise at increased risk of returning to alcohol abuse.

For this study, researchers combined positron emission tomography (PET) with computed tomography (CT). The PET imaging agent F-18 FPEB, which binds with mGluR5 receptors, was administered to 16 recently sober subjects, ranging from 32 to 57 years of age, and 32 healthy controls with no alcoholism in their backgrounds. Participants then underwent quantitative PET/CT imaging that measured respective mGluR5 receptor binding. Subjects also provided a drinking history and underwent hair analysis to evaluate their drinking pattern. Quantitative PET/CT results showed significantly reduced mGluR5 availability in the bilateral cingulate, caudate and insular cortex of the limbic systems in alcohol-dependent subjects regardless of age, gender or smoking status when compared to healthy controls.

“Collectively, these findings strongly substantiate the development of mGluR5-targeted therapies that heal or protect against the dysfunctional brain circuitry that characterizes alcohol addiction,” said Gil Leurquin-Sterk, M.D., first author of the study

For more information: www.snmmi.org

Related Content

News | Enterprise Imaging | May 25, 2017
At the 2017 annual meeting of the Society for Imaging Informatics in Medicine (SIIM), June 1-3 in Pittsburgh, Konica...
Targeted MRI Could Pinpoint Aggressive Prostate Cancers Before They Spread

The ZD2-Gd probe, represented by the orange ball and green arrow, binds to the EDB-FN in the prostate cancer cells with high metastatic potential. This results in a strong MRI signal (upper right). Prostate cancer cells with low metastatic potential have no EDB-FN and so there is no MRI signal (lower right). Credit: Han, et al., Bioconjug Chem-Apr-2017

News | Prostate Cancer | May 24, 2017
A research team funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) has engineered a...
Barco Presents Multimodality Imaging Display Solutions at SIIM 2017
News | Flat Panel Displays | May 24, 2017
Barco announced that several of its diagnostic display systems will be on display at the 2017 Society for Imaging...
New Research Finds Radiologists Serve More CMS Beneficiaries Each Year Than Other Specialties
News | Business | May 23, 2017
According to a new study, diagnostic radiologists on average serve more unique Medicare beneficiaries each year than...
Asterias MRI Data Shows AST-OPC1 Cells Prevent Cavitation in Severe Spinal Cord Injury Patients
News | Orthopedic Imaging | May 23, 2017
Asterias Biotherapeutics Inc. recently announced new positive serial magnetic resonance imaging (MRI) data from its...
Norwegian Study Confirms Benefits of Pressure-Based Breast Compression for Mammography
News | Mammography | May 22, 2017
Sigmascreening recently announced that a large independent Norwegian study further confirms Sigma’s hypothesis that...
Lantheus and GE Healthcare Sign Agreement for Worldwide Development, Commercialization of Flurpiridaz F-18
News | Radiopharmaceuticals and Tracers | May 22, 2017
May 22, 2017 — Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., and GE Healthcare announced t
ACR Select Extended to Cover Pediatric Imaging Indications and Exams
News | Clinical Decision Support | May 17, 2017
May 17, 2017 — Through the support of the American College of Radiology and the contribution of leading experts from
Seno Medical's Imagio Opto-Acoustic Breast Imaging System Proves Strong Predictor of Malignancy
News | Breast Imaging | May 16, 2017
Seno Medical Instruments Inc. recently announced that is Imagio opto-acoustic (OA/US) breast imaging system results...
Study Indicates Q-Collar May Help Protect Football Players' Brain Function
News | Neuro Imaging | May 15, 2017
A new study of high school football players adds to mounting evidence that the Q-Collar may help reduce brain injury...
Overlay Init